| Issue Date | Title | Author(s) |
| 2021-05-05 | Advanced drug delivery systems targeting NF-κB in respiratory diseases | Prasher, P; Sharma, M; Chellappan, DK; Gupta, G; Jha, NK; Singh, SK; MacLoughlin, R; Pinto, TJA; Lobenberg, R; Dua, K |
| - | Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases | Chan, Y; MacLoughlin, R; Zacconi, FC; Tambuwala, MM; Pabari, RM; Singh, SK; Jesus Andreoli Pinto, TD; Gupta, G; Chellappan, DK; Dua, K |
| - | Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 Cells | Paudel, KR; Panth, N; Manandhar, B; Singh, SK; Gupta, G; Wich, PR; Nammi, S; MacLoughlin, R; Adams, J; Warkiani, ME; Chellappan, DK; Oliver, BG; Hansbro, PM; Dua, K |
| - | Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro | Paudel, KR; Mehta, M; Yin, GHS; Yen, LL; Malyla, V; Patel, VK; Panneerselvam, J; Madheswaran, T; MacLoughlin, R; Jha, NK; Gupta, PK; Singh, SK; Gupta, G; Kumar, P; Oliver, BG; Hansbro, PM; Chellappan, DK; Dua, K |
| 2021 | Berberine-Loaded Liquid Crystalline Nanoparticles Inhibit Non-Small Cell Lung Cancer Proliferation and Migration in Vitro | Paudel, KR; Mehta, M; Yin, GHS; Yen, LL; Malyla, V; Patel, VK; Panneerselvam, J; Madheswaran, T; MacLoughlin, R; Jha, NK; Gupta, PK; Singh, SK; Gupta, G; Kumar, P; Oliver, BG; Hansbro, PM; Chellappan, DK; Dua, K |
| 2021-01 | COVID-19 in underlying COPD Patients. | Sunkara, K; Allam, VR; Shukla, SD; Chellappan, DK; Gupta, G; MacLoughlin, R; Dua, K |
| 2021-09 | Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects | Gulati, N; Chellappan, DK; MacLoughlin, R; Dua, K; Dureja, H |
| - | Mitochondrial dysfunctions associated with chronic respiratory diseases and their targeted therapies: an update | Chellappan, DK; Dharwal, V; Paudel, KR; Jha, NK; MacLoughlin, R; Oliver, BG; M Hansbro, P; Dua, K |
| 2021-09 | Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective | Chan, Y; Ng, SW; Singh, SK; Gulati, M; Gupta, G; Chaudhary, SK; Hing, GB; Collet, T; MacLoughlin, R; Löbenberg, R; Oliver, BG; Chellappan, DK; Dua, K |
| 2021-03 | Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro | Paudel, KR; Wadhwa, R; Tew, XN; Lau, NJX; Madheswaran, T; Panneerselvam, J; Zeeshan, F; Kumar, P; Gupta, G; Anand, K; Singh, SK; Jha, NK; MacLoughlin, R; Hansbro, NG; Liu, G; Shukla, SD; Mehta, M; Hansbro, PM; Chellappan, DK; Dua, K |
| 2021-02 | Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. | Lee, L-Y; Hew, GSY; Meenu,; Shukla, SD; Satija, S; Khurana, N; Anand, K; Dureja, H; Singh, SK; Mishra, V; Singh, PK; Gulati, M; Prasher, P; Aljabali, AAA; Tambuwala, MM; Thangavelu, L; Panneerselvam, J; Gupta, G; Zacconi, FC; Shastri, M; Jha, NK; Xenaki, D; MacLoughlin, R; Oliver, BG; Chellappan, DK; Dua, K |
| - | Treatment of chronic airway diseases using nutraceuticals: Mechanistic insight | Allam, VSRR; Chellappan, DK; Jha, NK; Shastri, MD; Gupta, G; Shukla, SD; Singh, SK; Sunkara, K; Chitranshi, N; Gupta, V; Wich, PR; MacLoughlin, R; Oliver, BGG; Wernersson, S; Pejler, G; Dua, K |
| 2022-02 | Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models | Tan, CL; Chan, Y; Candasamy, M; Chellian, J; Madheswaran, T; Sakthivel, LP; Patel, VK; Chakraborty, A; MacLoughlin, R; Kumar, D; Verma, N; Malyla, V; Gupta, PK; Jha, NK; Thangavelu, L; Devkota, HP; Bhatt, S; Prasher, P; Gupta, G; Gulati, M; Singh, SK; Paudel, KR; Hansbro, PM; Oliver, BG; Dua, K; Chellappan, DK |
